At the time of writing, Inari Medical Inc [NARI] stock is trading at $55.59, down -1.35%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NARI shares have gain 8.83% over the last week, with a monthly amount glided 9.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on September 18, 2024, when Stifel initiated its Hold rating and assigned the stock a price target of $50. Previously, Leerink Partners started tracking the stock with Market Perform rating on September 03, 2024, and set its price target to $47. On August 09, 2024, Deutsche Bank initiated with a Buy rating and assigned a price target of $68 on the stock. William Blair started tracking the stock assigning a Outperform rating. Needham downgraded its rating to a Hold. Piper Sandler downgraded its rating to Neutral for this stock on February 29, 2024, and downed its price target to $55. In a note dated January 23, 2024, Needham initiated an Buy rating and provided a target price of $72 on this stock.
For the past year, the stock price of Inari Medical Inc fluctuated between $36.73 and $67.13. Currently, Wall Street analysts expect the stock to reach $64 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $55.59 at the most recent close of the market. An investor can expect a potential return of 15.13% based on the average NARI price forecast.
Analyzing the NARI fundamentals
According to Inari Medical Inc [NASDAQ:NARI], the company’s sales were 574.50M for trailing twelve months, which represents an 21.39% jump. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.53 points at the first support level, and at 53.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 56.87, and for the 2nd resistance point, it is at 58.15.
Ratios To Look Out For
It is important to note that Inari Medical Inc [NASDAQ:NARI] has a current ratio of 1.77. Further, the Quick Ratio stands at 1.40, while the Cash Ratio is 0.28. Considering the valuation of this stock, the price to sales ratio is 5.59, the price to book ratio is 7.47.
Transactions by insiders
Recent insider trading involved MITCH HILL, Officer, that happened on Dec 12 ’24 when 3000.0 shares were purchased. Chief Medical Officer, Tu Thomas completed a deal on Dec 10 ’24 to sell 4000.0 shares. Meanwhile, Officer THOMAS TU bought 4000.0 shares on Dec 10 ’24.
